Shanghai Pioneer Holding Ltd
Research Shanghai Pioneer Holding Ltd (1345.HK) on Bullrun: market cap HKD 2.40B, P/E 17.3, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1345.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyHKD
- Market capHKD 2.40B
- P/E17.3
- Dividend yield2.6%
- Financial periodFY2025
- RevenueCNY 1.28B
- Revenue growth-16.2%
- Net incomeCNY 114.38M
- Free cash flowCNY 179.25M
- Gross margin48.9%
Valuation Snapshot
latest market cap is HKD 2.40B; P/E is 17.3; dividend yield is 2.6%.
Peer valuation comparison
Latest P/E is 17.25x versus a Healthcare sector median of 21.69x (20.5% below).
Latest dividend yield is 2.61% versus a Healthcare sector median of 2.41% (8.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.28B | CNY 114.38M | CNY 179.25M | 48.9% | 0.1 | CNY 166.61M | CNY 121.39M | CNY 1.05B |
| FY2024 | CNY 1.53B | CNY 151.62M | CNY 159.63M | 44.6% | 0.13 | CNY 103.57M | CNY 75.22M | CNY 1.11B |
| FY2023 | CNY 1.57B | CNY 138.52M | -CNY 163.24M | 42.7% | 0.12 | CNY 114.43M | CNY 74.02M | CNY 1.01B |
| FY2022 | CNY 1.56B | CNY 235.30M | CNY 18.99M | 50.2% | 0.2 | CNY 214.01M | CNY 37.59M | CNY 1.01B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 2.40B | 17.3 | 5.4% | 0.11 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.11 HKD, yield 2.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.12 CNY |
| FY2024 | 0.07 CNY |
| FY2023 | 0.07 CNY |
| FY2022 | 0.08 CNY |
About Shanghai Pioneer Holding Ltd
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shanghai Pioneer Holding Ltd's market cap?
Shanghai Pioneer Holding Ltd's market capitalization is HKD 2.40B.
What is Shanghai Pioneer Holding Ltd's P/E ratio?
Shanghai Pioneer Holding Ltd's price-to-earnings (P/E) ratio is 17.3.
Does Shanghai Pioneer Holding Ltd pay a dividend?
Shanghai Pioneer Holding Ltd has a dividend yield of 2.6%.
What does Shanghai Pioneer Holding Ltd do?
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products.